GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Luzhu Biotechnology Co Ltd (HKSE:02480) » Definitions » Enterprise Value

Beijing Luzhu Biotechnology Co (HKSE:02480) Enterprise Value : HK$6,389.09 Mil (As of May. 12, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Beijing Luzhu Biotechnology Co Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Beijing Luzhu Biotechnology Co's Enterprise Value is HK$6,389.09 Mil. Beijing Luzhu Biotechnology Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-271.81 Mil. Therefore, Beijing Luzhu Biotechnology Co's EV-to-EBIT ratio for today is -23.51.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Beijing Luzhu Biotechnology Co's Enterprise Value is HK$6,389.09 Mil. Beijing Luzhu Biotechnology Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-271.81 Mil. Therefore, Beijing Luzhu Biotechnology Co's EV-to-EBITDA ratio for today is -23.51.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Beijing Luzhu Biotechnology Co's Enterprise Value is HK$6,389.09 Mil. Beijing Luzhu Biotechnology Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was HK$0.00 Mil. Therefore, Beijing Luzhu Biotechnology Co's EV-to-Revenue ratio for today is .


Beijing Luzhu Biotechnology Co Enterprise Value Historical Data

The historical data trend for Beijing Luzhu Biotechnology Co's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Luzhu Biotechnology Co Enterprise Value Chart

Beijing Luzhu Biotechnology Co Annual Data
Trend Dec21 Dec22 Dec23
Enterprise Value
- - 5,408.87

Beijing Luzhu Biotechnology Co Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23
Enterprise Value - - - 7,222.26 5,408.87

Competitive Comparison of Beijing Luzhu Biotechnology Co's Enterprise Value

For the Biotechnology subindustry, Beijing Luzhu Biotechnology Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Luzhu Biotechnology Co's Enterprise Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Luzhu Biotechnology Co's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Beijing Luzhu Biotechnology Co's Enterprise Value falls into.



Beijing Luzhu Biotechnology Co Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Beijing Luzhu Biotechnology Co's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as

Beijing Luzhu Biotechnology Co's Enterprise Value for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Luzhu Biotechnology Co  (HKSE:02480) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Beijing Luzhu Biotechnology Co's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=6389.093/-271.81
=-23.51

Beijing Luzhu Biotechnology Co's current Enterprise Value is HK$6,389.09 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Beijing Luzhu Biotechnology Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-271.81 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Beijing Luzhu Biotechnology Co's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=6389.093/-271.81
=-23.51

Beijing Luzhu Biotechnology Co's current Enterprise Value is HK$6,389.09 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Beijing Luzhu Biotechnology Co's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-271.81 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Beijing Luzhu Biotechnology Co's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=6389.093/0
=

Beijing Luzhu Biotechnology Co's current Enterprise Value is HK$6,389.09 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Beijing Luzhu Biotechnology Co's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was HK$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beijing Luzhu Biotechnology Co Enterprise Value Related Terms

Thank you for viewing the detailed overview of Beijing Luzhu Biotechnology Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Luzhu Biotechnology Co (HKSE:02480) Business Description

Traded in Other Exchanges
N/A
Address
No. 3 Guangtong Street, Industrial Development Zone, Zhangjiawan Tongzhou District, Beijing, CHN
Beijing Luzhu Biotechnology Co Ltd is a biotechnology company committed to developing innovative human vaccines and therapeutic biologics to prevent and control infectious diseases and treat cancer and autoimmune diseases. Its clinical-stage product candidates comprise one vaccine candidate, LZ901 and two antibody injection product candidates, including K3 and K193. LZ901 is our Core Product.

Beijing Luzhu Biotechnology Co (HKSE:02480) Headlines

No Headlines